Report #2885556

Overview

Sex

Unknown

Age

Age unknown

State

TX

Recovered

Unknown

Vaccinated

—

Onset

—

Days to onset

—

Hospital days

—

Symptoms (2)

Symptom narrative

patient not being able to receive the IPOL dose as scheduled with no reported adverse event; Initial information received on 10-Feb-2026 regarding an unsolicited valid non-serious case received from a other health professional. This case involves an unknown age and gender patient who had not being able to receive the IPV (VERO) [IPOL] dose as scheduled with no reported adverse event. The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided. On an unknown date, the patient had not being able to receive IPV (VERO) Suspension for injection (strength: unknown, expiry date: 30-SEp-2027 and lot Y1D49P1) for immunization dose as scheduled with no reported adverse event (inappropriate schedule of product administration) (same day latency). Action taken: not applicable. This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in the Directive 2001/83/EC and Module VI of the Good Pharmacovigilance Practices. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.